Vaxart Stock (NASDAQ:VXRT), Quotes and News Summary

Q: What sector and industry does Vaxart (VXRT) operate in?

Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vaxart Stock (NASDAQ: VXRT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	500.000 / 1.944M
Day Range	- - -
52 Wk Range	0.530 - 1.590
Market Cap	$140.828M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	24
Short Interest	9.94%
Days to Cover	9.7

Recent News

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on revenue of $6.17 billion. AMD shares dipped 3.8% to $165.49 on Wednesday.

Avi Kapoor

What's Going On With Vaxart Stock Today?

Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.

Henry Khederian

What's Going On With Vaxart (VXRT) Stock?

Vaxart shares are trading higher by 17.8% Tuesday morning amid multiple news items. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Vaxart Inc

Sector

Health Care

Industry

Biotechnology

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vaxart (VXRT) stock?

You can purchase shares of Vaxart (NASDAQ: VXRT) through any online brokerage.

View our list of the best stock brokerages.

Who are Vaxart's (VXRT) competitors?

Other companies in Vaxart’s space includes: Zura Bio (NASDAQ:ZURA), Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), Vistagen Therapeutics (NASDAQ:VTGN) and GlycoMimetics (NASDAQ:GLYC).

What is the target price for Vaxart (VXRT) stock?

The latest price target for Vaxart (NASDAQ: VXRT) was reported by B. Riley Securities on Wednesday, January 31, 2024. The analyst firm set a price target for 2.00 expecting VXRT to rise to within 12 months (a possible 146.91% upside). 3 analyst firms have reported ratings in the last year.

Current Stock Price for Vaxart (VXRT)?

The stock price for Vaxart (NASDAQ: VXRT) is $0.81 last updated Today at April 19, 2024 at 7:00 AM EDT.

Does Vaxart (VXRT) pay a dividend?

There are no upcoming dividends for Vaxart.

When is Vaxart (NASDAQ:VXRT) reporting earnings?

Vaxart’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Vaxart (VXRT) going to split?

There is no upcoming split for Vaxart.

What sector and industry does Vaxart (VXRT) operate in?

Vaxart is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-